Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity (Q33370812)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity |
scientific article |
Statements
1 reference
Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity (English)
1 reference
Sandra J Strauss
1 reference
Ama Rohatiner
1 reference
T Andrew Lister
1 reference
Lenushka Maharaj
1 reference
Susan Hoare
1 reference
Sarah Vinnecombe
1 reference
Lynda Millard
1 reference
Anthony Boral
1 reference
Elizabeth Trehu
1 reference
David Schenkein
1 reference
Simon P Joel
1 reference
10 April 2006
1 reference
1 reference
24
1 reference
13
1 reference
2105-2112
1 reference
Identifiers
1 reference
1 reference